Telecommunications Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecommunications Press Releases.

Press releases published on September 8, 2026

Sep. 8, 2026

Generate Biomedicines Inc. to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

Sep. 8, 2026

Lantronix CEO to Participate in Upcoming Investor and Industry Events

Indeterminate GlobeNewswire

Sep. 8, 2026

Robinson Unmanned R44 AIRTRUCK Demonstrates Offshore Cargo Capabilities at Acadiana Regional Airport in Louisiana

Indeterminate GlobeNewswire

Sep. 8, 2026

Microchip’s 1.2V Clock Buffers Link Latest SoCs and FPGAs with Higher Voltage Components

Indeterminate GlobeNewswire

Sep. 8, 2026

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire

Sep. 8, 2026

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics

Indeterminate GlobeNewswire

Sep. 8, 2026

LiveU, AP bring new connectivity, workflow tech to global newsgathering, deploying largest LU900Q fleet worldwide

Indeterminate GlobeNewswire

Sep. 8, 2026

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

G3 Goldfields Provides Update on Listing

Indeterminate GlobeNewswire

Sep. 8, 2026

CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire

Sep. 8, 2026

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Indeterminate GlobeNewswire

Sep. 8, 2026

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

Sep. 8, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

Sep. 8, 2026

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

Sep. 8, 2026

Del Taco Celebrates #1 Fast Food Honors With Free Tacos in Port St. Lucie

Indeterminate GlobeNewswire